Karachi, Pakistan

Aqeel Ahmed

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aqeel Ahmed. Retrieved from https://idiyas.com/inventor/aqeel-ahmed

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,513 
Other
 patents

Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Aqeel Ahmed

Introduction

Aqeel Ahmed is a prominent inventor based in Karachi, Pakistan. He has made significant contributions to the field of biomedical research, particularly in the development of anticancer therapies. His work focuses on creating innovative solutions to combat cancer, showcasing his dedication to improving health outcomes.

Latest Patents

Aqeel Ahmed holds a patent for his invention titled "Anticancer peptides." This invention provides new anticancer analogs of the antimicrobial peptide temporin-SHa. The new analogs (SEQ ID NOs: 2-6) of temporin SHa, along with two different conjugates (7 & 8) comprising monomeric and dimeric forms of SEQ ID NO 4 with cancer-targeting ligands, have been identified as effective anticancer peptides. This patent highlights his commitment to advancing cancer treatment options.

Career Highlights

Throughout his career, Aqeel has demonstrated a strong focus on research and innovation. His work has not only contributed to scientific knowledge but has also paved the way for potential therapeutic applications. His dedication to his field is evident in the quality and impact of his research.

Collaborations

Aqeel Ahmed has collaborated with notable colleagues, including Almas Jabeen and Muhammad Nadeem-ul-Haque. These partnerships have enriched his research endeavors and fostered a collaborative environment for innovation.

Conclusion

Aqeel Ahmed's contributions to the field of anticancer research exemplify the spirit of innovation and dedication to improving health outcomes. His patent on anticancer peptides represents a significant step forward in the fight against cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…